Efficacy of adjuvant immune checkpoint inhibitors pembrolizumab or nivolumab in melanoma patients ㉥ 75 years: results of a real-world cohort including 456 patients

Author:

Gawaz, A.; Wolff, I.; Nanz, L.; Flatz, L.; Forschner, A.

Tübinger Autor(en):

Published in:

Cancer Immunology Immunotherapy (2024), Bd. 73 (9), Article 185

Verlagsangabe:

New York : Springer

Language:

English

Full text:

ISSN:

0340-7004

DDC Classifikation:

570 - Life sciences; biology
610 - Medicine and health

Dokumentart:

Article

This item appears in the following Collection(s)